July 03, 2020
Nadim Yared, CEO of CVRx This week, CVRX reported positive six-month trial results for its Barostim Neo, an FDA-approved treatment for heart failure. The...
00:47:21
September 27, 2024
Can Biolinq shine new light on measuring glucose? CEO Yang makes a case here and at DeviceTalks West In this podcast episode, Biolinq CEO...
00:45:55
March 11, 2022
In this week’s podcast, we’ll speak with Sally Saba, MD, Medtronic’s chief inclusion and diversity officer, about the company’s work to create a more...
01:21:24